Intestinal Microbiota Transplant Prior to Allogeneic Stem Cell Transplant (MAST) Trial | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Intestinal Microbiota Transplant Prior to Allogeneic Stem Cell Transplant (MAST) Trial	Chronic Disease, Disease Attributes, Hemic and Lymphatic Diseases, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Myeloproliferative Disorders, Neoplasms by Histologic Type, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Precursor Cell Lymphoblastic Leukemia-Lymphoma, acute biphenotypic leukemia, acute leukemia of ambiguous lineage, acute myeloid leukemia, bone marrow disorder, chronic myelomonocytic leukemia, hematologic disorder, immune system disorder, immunoproliferative disorder, leukemia, lymphatic system disorder, lymphoid leukemia, lymphoproliferative syndrome, myelodysplastic syndrome, myelodysplastic/myeloproliferative disease, myeloid leukemia, neoplasm	Recruiting	Phase 2	2025-04-17		NCT06355583

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Imperial College London	220

8 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Imperial College Healthcare NHS Trust	London	United Kingdom	2
Kings College NHS Foundation Trust	London	United Kingdom	1
Leeds Teaching Hospital NHS Trust	Leeds	United Kingdom	1
Manchester University NHS Foundation Trust	Manchester	United Kingdom	22
Manchester University NHS Trust	Manchester	United Kingdom	2
Royal Mardsen Hostpital	London	United Kingdom	1
University College London Hospitals NHS Trust	London	United Kingdom	1
University Hospitals Birmingham NHS Foundation Trust	Birmingham	United Kingdom	1